Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas

Proteomics

Volumn 15, Issue 2-3, 2015, Pages 394-407

  Sharma, Samridhi ^a   Ray, Sandipan ^a   Mukherjee, Shuvolina ^a   Moiyadi, Aliasgar ^b   Sridhar, Epari ^b   Srivastava, Sanjeeva ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

ITRAQ; Meningiomas; Signal transduction; Surrogate markers; Tissue proteomics

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ALDEHYDE DEHYDROGENASE; CALCYCLIN; CALGRANULIN B; CAVEOLIN; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; HISTONE; INTEGRIN; RAS PROTEIN; VINCULIN; WNT PROTEIN; PROTEOME;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ELECTROSPRAY QUADRUPOLE TIME OF LIGHT MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MENINGIOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION; AGED; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN PROTEIN INTERACTION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84921322632     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201400328     Document Type: Article

References (80)

1. Long, D. M., Non-glial tumors of the brain: tumors of the cerebellopontine angle and meningiomas. Curr. Opin. Neurol. Neurosurg. 1992, 5, 813-817.
2. Mawrin, C., Perry, A., Pathological classification and molecular genetics of meningiomas. J. Neurooncol. 2010, 99, 379-391.
3. Hallinan, J. T., Hegde, A. N., Lim, W. E., Dilemmas and diagnostic difficulties in meningioma. Clin. Radiol. 2013, 68, 837-844.
4. Herrmann, A., Ooi, J., Launay, S., Searcy, J. L. et al., Proteomic data in meningiomas: post-proteomic analysis can reveal novel pathophysiological pathways. J. Neurooncol. 2011, 104, 401-410.
5. Wiemels, J., Wrensch, M., Claus, E. B., Epidemiology and etiology of meningioma. J. Neurooncol. 2010, 99, 307-314.
6. Durand, A., Labrousse, F., Jouvet, A., Bauchet, L. et al., WHO grade II and III meningiomas: a study of prognostic factors. J. Neurooncol. 2009, 95, 367-375.
7. Choudhary, C., Mann, M., Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 2010, 11, 427-439.
8. Levitzki, A., Klein, S., Signal transduction therapy of cancer. Mol. Aspects Med. 2010, 31, 287-329.
9. Chan, S. M., Ermann, J., Su, L., Fathman, C. G., Utz, P. J., Protein microarrays for multiplex analysis of signal transduction pathways. Nat. Med. 2004, 10, 1390-1396.
10. Sheffield, L. G., Gavinski, J. J., Proteomics methods for probing molecular mechanisms in signal transduction. J. Anim. Sci. 2003, 81(Suppl 3), 48-57.
11. Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., Liotta, L. A., Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 2002, 1, 683-695.
12. Okomoto, H., Li, J., Vortmeyer, A. O., Jaffe, H. et al., Comparative proteomic profiles of meningioma subtypes. Cancer Res. 2006, 66, 10199-10204.
13. Melchior, K., Tholey, A., Heisel, S., Keller, A. et al., Proteomic study of human glioblastoma multiforme tissue employing complementary two-dimensional liquid chromatography- and mass spectrometry-based approaches. J. Proteome Res. 2009, 8, 4604-4614.
14. Polisetty, R. V., Gautam, P., Sharma, R., Harsha, H. C. et al., LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions. Mol. Cell. Proteomics 2012, 11, M111.013565.
15. Kolch, W., Pitt, A., Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat. Rev. Cancer 2010, 10, 618-629.
16. Wang, J., Peng, X., Peng, W., Wu, F. X., Dynamic protein interaction network construction and applications. Proteomics 2014, 14, 338-352.
17. Reddy, P. J., Rao, A. A., Malhotra, D., Sharma, S. et al., A simple protein extraction method for proteomic analysis of diverse biological specimens. Curr. Proteomics, 2014, 10, 298-311.
18. Thomas, P. D., Kejariwal, A., Guo, N., Mi, H. et al., Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res. 2006, 34(Web Server issue), W645-W650.
19. Huang, d. W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
20. Watson, M. A., Gutmann, D. H., Peterson, K., Chicoine, M. R. et al., Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am. J. Pathol. 2002, 161, 665-672.
21. Ray, S., Renu, D., Srivastava, R., Gollapalli, K. et al., Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One 2012, 7, e41751.
22. Kim, J. H., Lee, S. K., Yoo, Y. C., Park, N. H. et al., Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma. Med. Sci. Monit. 2012, 18, BR450-BR460.
23. Saydam, O., Senol, O., Schaaij-Visser, T. B., Pham, T. V. et al., Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J. Proteome Res. 2010, 9, 485-494.
24. Blume-Jensen, P., Hunter, T., Oncogenic kinase signalling. Nature 2001, 411, 355-365.
25. Cuevas, I. C., Slocum, A. L., Jun, P., Costello, J. F. et al., Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res. 2005, 65, 5070-5075.
26. Laurendeau, I., Ferrer, M., Garrido, D., D'Haene, N. et al., Gene expression profiling of the hedgehog signaling pathway in human meningiomas. Mol. Med. 2010, 16, 262-270.
27. Johnson, M. D., Okediji, E., Woodard, A., Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways. J. Neurooncol. 2004, 66, 9-16.
28. Bello, L., Zhang, J., Nikas, D. C., Strasser, J. F. et al., Alpha(v)beta3 and alpha(v)beta5 integrin expression in meningiomas. Neurosurgery 2000, 47, 1185-1195.
29. Tsai, B. P., Hoverter, N. P., Waterman, M. L., Blending hippo and WNT: sharing messengers and regulation. Cell 2012, 151, 1401-1403.
30. Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L. et al., Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012, 150, 780-791.
31. Yu, F. X., Guan, K. L., The Hippo pathway: regulators and regulations. Genes Dev. 2013, 27, 355-371.
32. Choi, S. H., Estaras, C., Moresco, J. J., Yates, J. R., III, Jones, K. A., Alpha-catenin interacts with APC to regulate beta-catenin proteolysis and transcriptional repression of Wnt target genes. Genes Dev. 2013, 27, 2473-2488.
33. Kohn, A. D., Moon, R. T., Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 2005, 38, 439-446.
34. Taipale, J., Beachy, P. A., The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411, 349-354.
35. Hart, S., Fischer, O. M., Prenzel, N., Zwick-Wallasch, E. et al., GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol. Chem. 2005, 386, 845-855.
36. Salama, I., Malone, P. S., Mihaimeed, F., Jones, J. L., A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 2008, 34, 357-364.
37. Svenningsson, P., Greengard, P., p11 (S100A10)-an inducible adaptor protein that modulates neuronal functions. Curr. Opin. Pharmacol. 2007, 7, 27-32.
38. Myrvang, H. K., Guo, X., Li, C., Dekker, L. V., Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells. FEBS Lett. 2013, 587, 3210-3215.
39. Hirota, Y., Tachibana, O., Uchiyama, N., Hayashi, Y. et al., Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Clin. Neurol. Neurosurg. 2009, 111, 127-133.
40. Cui, G. Q., Jiao, A. H., Xiu, C. M., Wang, Y. B. et al., Proteomic analysis of meningiomas. Acta Neurol. Belg. 2014, 114, 187-194.
41. Bouamrani, A., Ramus, C., Gay, E., Pelletier, L. et al., Increased phosphorylation of vimentin in noninfiltrative meningiomas. PLoS One 2010, 5, e9238.
42. Gogineni, V. R., Nalla, A. K., Gupta, R., Dinh, D. H. et al., Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett. 2011, 313, 64-75.
43. Felding-Habermann, B., O'Toole, T. E., Smith, J. W., Fransvea, E. et al., Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA 2001, 98, 1853-1858.
44. Hsu, Y. L., Wu, C. Y., Hung, J. Y., Lin, Y. S. et al., Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin alpha6beta4 and Notch1/Jagged2 signaling pathway. Carcinogenesis 2013, 34, 1370-1381.
45. Barbieri, F., Bajetto, A., Porcile, C., Pattarozzi, A. et al., CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation. Ann. NY Acad. Sci. 2006, 1090, 332-343.
46. Bajetto, A., Barbieri, F., Pattarozzi, A., Dorcaratto, A. et al., CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro. Oncol. 2007, 9, 3-11.
47. Bollrath, J., Greten, F. R., IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumor promotion and metastasis. EMBO Rep. 2009, 10, 1314-1319.
48. Salvucci, O., Bouchard, A., Baccarelli, A., Deschenes, J. et al., The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res. Treat. 2006, 97, 275-283.
49. Bergoglio, M. T., Gomez-Balaguer, M., Almonacid, F. E., Hurtado, M. F., Hernandez-Mijares, A., Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol. Nutr. 2013, 60, 264-267.
50. Kottler, M. L., Starzec, A., Carre, M. C., Lagarde, J. P. et al., The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int. J. Cancer 1997, 71, 595-599.
51. Limonta, P., Moretti, R. M., Montagnani, M. M., Motta, M., The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front. Neuroendocrinol. 2003, 24, 279-295.
52. Wilkinson, S. J., Kucukmetin, A., Cross, P., Darby, S. et al., Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer. Hum. Pathol. 2008, 39, 1197-1204.
53. Hwang, S. L., Chang, J. H., Cheng, T. S., Sy, W. D. et al., Expression of Rac3 in human brain tumors. J. Clin. Neurosci. 2005, 12, 571-574.
54. Sanz-Moreno, V., Marshall, C. J., The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr. Opin. Cell Biol. 2010, 22, 690-696.
55. Kwiatkowska, A., Didier, S., Fortin, S., Chuang, Y. et al., The small GTPase RhoG mediates glioblastoma cell invasion. Mol. Cancer 2012, 11, 65.
56. Chan, A. Y., Coniglio, S. J., Chuang, Y. Y., Michaelson, D. et al., Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005, 24, 7821-7829.
57. Carroll, R. S., Black, P. M., Zhang, J., Kirsch, M. et al., Expression and activation of epidermal growth factor receptors in meningiomas. J. Neurosurg. 1997, 87, 315-323.
58. Caltabiano, R., Barbagallo, G. M., Castaing, M., Cassenti, A. et al., Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study. J. Neurosurg. Sci. 2013, 57, 139-151.
59. Wang, X., Gong, Y., Wang, D., Xie, Q. et al., Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS One 2012, 7, e52707.
60. Glaysher, S., Bolton, L. M., Johnson, P., Atkey, N. et al., Targeting EGFR and PI3K pathways in ovarian cancer. Br. J. Cancer 2013, 109, 1786-1794.
61. Moerkens, M., Zhang, Y., Wester, L., van de Water, B., Meerman, J. H., Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation. BMC Cancer 2014, 14, 283.
62. Sabbatini, M., Comi, C., Chiocchetti, A., Piffanelli, V. et al., Signals of apoptotic pathways in several types of meningioma. Pathol. Oncol. Res. 2011, 17, 51-59.
63. Pareja, F., Macleod, D., Shu, C., Crary, J. F. et al., PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BAD. Mol. Cancer Res. 2014, 12, 987-1001.
64. Esposito, I., Kleeff, J., Abiatari, I., Shi, X. et al., Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer. J. Clin. Pathol. 2007, 60, 885-895.
65. Smith, A. J., Karpova, Y., D'Agostino, R., Jr., Willingham, M., Kulik, G., Expression of the Bcl-2 protein BAD promotes prostate cancer growth. PLoS One 2009, 4, e6224.
66. Ueba, T., Takahashi, J. A., Fukumoto, M., Ohta, M. et al., Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery 1994, 34, 221-225.
67. Johnson, M. D., O'Connell, M. J., Pilcher, W., Reeder, J. E., Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. J. Neurosurg. 2010, 112, 934-939.
68. Miyake, M., Sugano, K., Sugino, H., Imai, K. et al., Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer. Cancer Sci. 2010, 101, 250-258.
69. Zecchini, S., Bombardelli, L., Decio, A., Bianchi, M. et al., The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling. EMBO Mol. Med. 2011, 3, 480-494.
70. Saydam, O., Shen, Y., Wurdinger, T., Senol, O. et al., Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol. Cell Biol. 2009, 29, 5923-5940.
71. Pecina-Slaus, N., Nikuseva, M. T., Tomas, D., Beros, V. et al., Meningiomas exhibit loss of heterozygosity of the APC gene. J. Neurooncol. 2008, 87, 63-70.
72. Pate, K. T., Stringari, C., Sprowl-Tanio, S., Wang, K. et al., Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 2014, 33, 1454-1473.
73. Yu, M., Ting, D. T., Stott, S. L., Wittner, B. S. et al., RNA sequencing of pancreatic circulating tumor cells implicates WNT signalling in metastasis. Nature 2012, 487, 510-513.
74. Shu, J., Lee, J. H., Harwalkar, J. A., Oh-Siskovic, S. et al., Adenovirus-mediated gene transfer of dominant negative Ha-Ras inhibits proliferation of primary meningioma cells. Neurosurgery 1999, 44, 579-587.
75. Janes, P. W., Daly, R. J., deFazio, A., Sutherland, R. L., Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994, 9, 3601-3608.
76. Holland, E. C., Celestino, J., Dai, C., Schaefer, L. et al., Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 2000, 25, 55-57.
77. Carroll, R. S., Schrell, U. M., Zhang, J., Dashner, K. et al., Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas. Neurosurgery 1996, 38, 367-375.
78. Schrell, U. M., Nomikos, P., Fahlbusch, R., Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J. Neurosurg. 1992, 77, 288-294.
79. Moreno-Smith, M., Lee, S. J., Lu, C., Nagaraja, A. S. et al., Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Neoplasia 2013, 15, 502-510.
80. Sharma, S., Ray, S., Moiyadi, A., Sridhar, E. et al., Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers. Sci. Rep. 2014, 4, 7140.